• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of orally administered highly variable drugs and drug formulations.

作者信息

Shah V P, Yacobi A, Barr W H, Benet L Z, Breimer D, Dobrinska M R, Endrenyi L, Fairweather W, Gillespie W, Gonzalez M A, Hooper J, Jackson A, Lesko L J, Midha K K, Noonan P K, Patnaik R, Williams R L

机构信息

Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20855, USA.

出版信息

Pharm Res. 1996 Nov;13(11):1590-4. doi: 10.1023/a:1016468018478.

DOI:10.1023/a:1016468018478
PMID:8956322
Abstract
摘要

相似文献

1
Evaluation of orally administered highly variable drugs and drug formulations.口服高变异性药物及药物制剂的评估。
Pharm Res. 1996 Nov;13(11):1590-4. doi: 10.1023/a:1016468018478.
2
Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.随机试验中口服溶液与普通片的双氯芬酸钾的药代动力学差异：进食与禁食状态的影响。
Headache. 2015 Feb;55(2):265-75. doi: 10.1111/head.12483. Epub 2014 Dec 24.
3
Principles and criteria in the development and optimization of topical therapeutic products.局部治疗产品研发与优化的原则和标准
J Pharm Sci. 1992 Oct;81(10):1051-4. doi: 10.1002/jps.2600811020.
4
Dissolution modeling of bead formulations and predictions of bioequivalence for a highly soluble, highly permeable drug.珠粒制剂溶出建模及高溶解性、高渗透性药物生物等效性预测。
Mol Pharm. 2010 Oct 4;7(5):1450-7. doi: 10.1021/mp100118t. Epub 2010 Aug 12.
5
The search for orally active medications through combinatorial chemistry.通过组合化学寻找口服活性药物。
Med Res Rev. 1998 May;18(3):149-85. doi: 10.1002/(sici)1098-1128(199805)18:3<149::aid-med2>3.0.co;2-x.
6
Comparative bioavailability and pharmacokinetics of three formulations of albuterol.三种沙丁胺醇制剂的比较生物利用度和药代动力学
J Pharm Sci. 1985 Feb;74(2):217-9. doi: 10.1002/jps.2600740225.
7
Pediatric drug development: formulation considerations.儿科药物研发：剂型考量
Drug Dev Ind Pharm. 2014 Oct;40(10):1283-99. doi: 10.3109/03639045.2013.850713. Epub 2014 Jan 31.
8
On the BCS biowaivers of orally disintegrating tablets.关于口腔崩解片的生物药剂学分类豁免
Eur J Pharm Sci. 2015 Jan 23;66:107-8. doi: 10.1016/j.ejps.2014.10.009. Epub 2014 Oct 18.
9
Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.口服缓释制剂的生物利用度和生物等效性方面
AAPS J. 2017 Mar;19(2):360-366. doi: 10.1208/s12248-016-0025-9. Epub 2016 Dec 21.
10
The bioequivalence of highly variable drugs and drug products.高变异药物和药品的生物等效性。
Int J Clin Pharmacol Ther. 2005 Oct;43(10):485-98. doi: 10.5414/cpp43485.

引用本文的文献

1
Assessment of Pharmacokinetics and Safety with Bioequivalence of the Nitroglycerin Sublingual Tablets of Two Formulations in Chinese Healthy Subjects: A Bioequivalence Study.两种制剂的硝酸甘油舌下片在中国健康受试者中的药代动力学、安全性及生物等效性评价：一项生物等效性研究
Drugs R D. 2025 Aug 8. doi: 10.1007/s40268-025-00519-4.
2
Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.超生物利用度伊曲康唑与传统伊曲康唑在不同剂量治疗皮肤癣菌病时的药代动力学及临床比较
Drugs Context. 2023 Jan 9;12. doi: 10.7573/dic.2022-8-1. eCollection 2023.
3
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization.
高变异药物的生物等效性：监管协议、分歧和协调。
J Pharmacokinet Pharmacodyn. 2019 Apr;46(2):117-126. doi: 10.1007/s10928-019-09623-w. Epub 2019 Feb 23.
4
Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study.普通阿仑膦酸钠片（70毫克）与福善美片（70毫克）在空腹健康志愿者中的生物等效性：一项随机、开放标签、三臂、参比制剂重复的交叉研究。
Drug Des Devel Ther. 2017 Jul 11;11:2109-2119. doi: 10.2147/DDDT.S138286. eCollection 2017.
5
Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its Control.I 类错误膨胀在评价比例平均生物等效性中的作用及控制方法。
Pharm Res. 2016 Nov;33(11):2805-14. doi: 10.1007/s11095-016-2006-1. Epub 2016 Aug 1.
6
Perspectives on variability in pharmacokinetics of an oral contraceptive product.口服避孕药产品药代动力学变异性的观点
Contraception. 2017 Jan;95(1):5-9. doi: 10.1016/j.contraception.2016.07.019. Epub 2016 Jul 27.
7
International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences.国际上用于口服全身可用仿制药生物等效性的指导原则：相似性和差异性的调查。
AAPS J. 2013 Oct;15(4):974-90. doi: 10.1208/s12248-013-9499-x. Epub 2013 Jul 3.
8
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.美国食品和药物管理局实施参照标度平均生物等效性方法评估高度变异仿制药产品。
AAPS J. 2012 Dec;14(4):915-24. doi: 10.1208/s12248-012-9406-x. Epub 2012 Sep 13.
9
Individualized, discrete event, simulations provide insight into inter- and intra-subject variability of extended-release, drug products.个体化的离散事件模拟为缓释药品的个体间和个体内变异性提供了深入见解。
Theor Biol Med Model. 2012 Aug 31;9:39. doi: 10.1186/1742-4682-9-39.
10
Bioequivalence of highly variable drugs: a comparison of the newly proposed regulatory approaches by FDA and EMA.高度变异药物的生物等效性：FDA 和 EMA 新提出的监管方法比较。
Pharm Res. 2012 Apr;29(4):1066-77. doi: 10.1007/s11095-011-0651-y. Epub 2011 Dec 28.